Cancer heterogeneity refers to the diversity within a tumor and between tumors in different patients. This variation can complicate treatment, as different cells within the same tumor can respond differently to therapy. Heterogeneity can lead to treatment resistance, where some cancer cells survive and continue to proliferate despite therapy. Personalized medicine, which tailors treatment based on the individual genetic makeup of the tumor, is an approach to address this challenge.
